These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 2575829)

  • 1. Nitric oxide and cytosolic guanylate cyclase: components of an intercellular signalling system.
    Böhme E; Schmidt HH
    Z Kardiol; 1989; 78 Suppl 6():75-9. PubMed ID: 2575829
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [NO, a hormonally active substance].
    Schmidt HH; Böhme E
    Med Monatsschr Pharm; 1990 Mar; 13(3):74-81. PubMed ID: 1969608
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical mechanisms underlying vascular smooth muscle relaxation: the guanylate cyclase-cyclic GMP system.
    Waldman SA; Murad F
    J Cardiovasc Pharmacol; 1988; 12 Suppl 5():S115-8. PubMed ID: 2469867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regulation and role of guanylate cyclase-cyclic GMP in vascular relaxation.
    Murad F; Waldman S; Molina C; Bennett B; Leitman D
    Prog Clin Biol Res; 1987; 249():65-76. PubMed ID: 2890172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhaled nitric oxide decreases pulmonary soluble guanylate cyclase protein levels in 1-month-old lambs.
    Thelitz S; Bekker JM; Ovadia B; Stuart RB; Johengen MJ; Black SM; Fineman JR
    J Thorac Cardiovasc Surg; 2004 May; 127(5):1285-92. PubMed ID: 15115984
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli lipopolysaccharide downregulates soluble guanylate cyclase in pulmonary artery smooth muscle.
    Scott WS; Nakayama DK
    J Surg Res; 1998 Dec; 80(2):309-14. PubMed ID: 9878330
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nitric oxide-cyclic GMP pathway with some emphasis on cavernosal contractility.
    Ghalayini IF
    Int J Impot Res; 2004 Dec; 16(6):459-69. PubMed ID: 15229623
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Involvement of NO in the endothelium-independent relaxing effects of N(omega)-hydroxy-L-arginine and other compounds bearing a C=NOH function in the rat aorta.
    Vetrovsky P; Boucher JL; Schott C; Beranova P; Chalupsky K; Callizot N; Muller B; Entlicher G; Mansuy D; Stoclet JC
    J Pharmacol Exp Ther; 2002 Nov; 303(2):823-30. PubMed ID: 12388669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nitric oxide inhibits neutrophil beta 2 integrin function by inhibiting membrane-associated cyclic GMP synthesis.
    Banick PD; Chen Q; Xu YA; Thom SR
    J Cell Physiol; 1997 Jul; 172(1):12-24. PubMed ID: 9207921
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasorelaxing effects of propranolol in rat aorta and mesenteric artery: a role for nitric oxide and calcium entry blockade.
    Priviero FB; Teixeira CE; Toque HA; Claudino MA; Webb RC; De Nucci G; Zanesco A; Antunes E
    Clin Exp Pharmacol Physiol; 2006; 33(5-6):448-55. PubMed ID: 16700877
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin stimulates glucose transport via nitric oxide/cyclic GMP pathway in human vascular smooth muscle cells.
    Bergandi L; Silvagno F; Russo I; Riganti C; Anfossi G; Aldieri E; Ghigo D; Trovati M; Bosia A
    Arterioscler Thromb Vasc Biol; 2003 Dec; 23(12):2215-21. PubMed ID: 14615391
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Significance of endothelial cells for the regulation of the tone of smooth muscle--formation of an endothelial, relaxing factor].
    Förstermann U
    Z Kardiol; 1986 Oct; 75(10):577-83. PubMed ID: 2878541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Current knowledge on the formation of nitric oxide in endothelial cells of blood vessels, in nerve cells and macrophages as well as its significance in vascular dilatation, information transmission and damage of tumor cells].
    Kolb E
    Z Gesamte Inn Med; 1991 Aug; 46(12):431-6. PubMed ID: 1719706
    [TBL] [Abstract][Full Text] [Related]  

  • 14. cGMP accumulation and gene expression of soluble guanylate cyclase in human vascular tissue.
    Papapetropoulos A; Cziraki A; Rubin JW; Stone CD; Catravas JD
    J Cell Physiol; 1996 May; 167(2):213-21. PubMed ID: 8613461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Soluble guanylate cyclase: the forgotten sibling.
    Hobbs AJ
    Trends Pharmacol Sci; 1997 Dec; 18(12):484-91. PubMed ID: 9458697
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nitric oxide-evoked transient kinetics of cyclic GMP in vascular smooth muscle cells.
    Cawley SM; Sawyer CL; Brunelle KF; van der Vliet A; Dostmann WR
    Cell Signal; 2007 May; 19(5):1023-33. PubMed ID: 17207606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide and regulation of vascular tone: pharmacological and physiological considerations.
    McHugh J; Cheek DJ
    Am J Crit Care; 1998 Mar; 7(2):131-40; quiz 141-2. PubMed ID: 9509227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of NO/cGMP signaling in smooth muscle: blood vessels versus airways.
    Mullershausen F; Lange A; Mergia E; Friebe A; Koesling D
    Mol Pharmacol; 2006 Jun; 69(6):1969-74. PubMed ID: 16510560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. L-Citrulline, the by-product of nitric oxide synthesis, decreases vascular smooth muscle cell proliferation.
    Ruiz E; Del Rio M; Somoza B; Ganado P; Sanz M; Tejerina T
    J Pharmacol Exp Ther; 1999 Jul; 290(1):310-3. PubMed ID: 10381792
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamic association of nitric oxide downstream signaling molecules with endothelial caveolin-1 in rat aorta.
    Linder AE; McCluskey LP; Cole KR; Lanning KM; Webb RC
    J Pharmacol Exp Ther; 2005 Jul; 314(1):9-15. PubMed ID: 15778264
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.